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Abstract: Prion diseases are fatal neurodegenerative disorders that affect animals and humans. 
There is a need to gain understanding of prion disease pathogenesis and to develop diagnostic 
assays to detect prion diseases prior to the onset of clinical symptoms. The goal of this study 
was to identify genes that show altered expression early in the disease process in the spleen and 
brain of prion disease-infected mice. Using Affymetrix microarrays, we identiﬁ  ed 67 genes that 
showed increased expression in the brains of prion disease-infected mice prior to the onset of 
clinical symptoms. These genes function in many cellular processes including immunity, the 
endosome/lysosome system, hormone activity, and the cytoskeleton. We conﬁ  rmed a subset 
of these gene expression alterations using other methods and determined the time course in 
which these changes occur. We also identiﬁ  ed 14 genes showing altered expression prior to the 
onset of clinical symptoms in spleens of prion disease infected mice. Interestingly, four genes, 
Atp1b1, Gh, Anp32a, and Grn, were altered at the very early time of 46 days post-infection. 
These gene expression alterations provide insights into the molecular mechanisms underlying 
prion disease pathogenesis and may serve as surrogate markers for the early detection and 
diagnosis of prion disease.
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Background
Transmissible spongiform encephalopathies (TSEs), also termed prion diseases, are 
fatal neurodegenerative disorders that occur in humans and various animal species. 
Examples include Creutzfeldt-Jakob disease (CJD) in humans; bovine spongiform 
encephalopathy (BSE) in cattle; chronic wasting disease (CWD) in deer and elk; and 
scrapie in sheep and experimental mice (Chesebro 2003). There is no test yet available 
for preclinical diagnosis of transmitted prion disease, nor is there an effective treatment 
available. In experimental models, certain drug treatments can prolong survival, but 
early intervention is essential to achieve this effect. We are faced with an urgent need 
to develop methods both to diagnose and to treat these diseases prior to the onset of 
clinical symptoms.
TSEs are characterized by vacuolation of the neuropil, neuron loss, activation 
of astrocytes and microglia, and in some situations the deposition of amyloid ﬁ  brils 
(Wells 1993; Budka et al 1995). These pathological changes are thought to depend 
on a misfolded partially protease-resistant isoform of endogenous prion protein, 
known as PrPsc or PrP-res (Prusiner 1982; McKinley et al 1983). The molecular 
mechanisms underlying the pathology are far from clear (Aguzzi and Polymenidou 
2004; Weissmann, 2004).
Oral infection is the major route of transmission for many TSEs, including BSE, 
CWD (Belay et al 2004), transmissible mink encephalopathy (Bartz et al 2003), 
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scrapie (Andreoletti et al 2000; van Keulen et al 2000), and 
variant CJD (Bruce et al 1997). After oral transmission, infec-
tivity passes through the gut to secondary immune tissues and 
then to the brain (Aguzzi and Heikenwalder 2005). Similar 
to oral infection, experimental intracerebral scrapie inocu-
lation also leads to the secondary lymphoid organs rapidly 
accumulating infectivity and misfolded prion proteins (Fraser 
and Dickinson 1970; Hunter et al 1972).
We hypothesize that genes involved in protein folding 
and genes that function in the endosome/lysosome system 
are important cofactors in the misfolding and accumulation 
of misfolded prion proteins and the propagation of scrapie 
infectivity. The rationale for this hypothesis include that: 
1) prion diseases involve prion protein misfolding (Prusiner 
1982; Aguzzi 2006), 2) the misfolding of prion proteins is 
thought to occur on the cell surface or in the endosome/
lysosome pathway (Caughey and Raymond 1991; Caughey 
et al 1991; Caughey 1993), 3) misfolded prion proteins 
accumulate in the endosome/lysosome system (McKinley 
et al 1991), 4) lysosomotropic agents and cysteine protease 
inhibitors inhibit the scrapie-associated accumulation of 
prion proteins (Doh-Ura et al 2000), and 5 ) we have identi-
ﬁ  ed a number of genes that function in protein folding and 
genes that function in the endosome/lysosome system that 
show increased expression during prion disease (Skinner 
et al 2006).
In a previous study using cDNA microarrays, we iden-
tiﬁ  ed 22 genes that showed increased expression in the 
brains of scrapie-infected mice prior to the onset of clinical 
symptoms (Skinner et al 2006). One goal of the present study 
was to expand our gene expression studies using Affymetrix 
430A microarrays (Santa Clara, CA), in order to identify 
additional alterations in expression that occur prior to the 
onset of clinical symptoms. The Affymetrix 430A microar-
rays contain over 14,000 unique genes, more than 7000 of 
which were not represented in the cDNA microarrays in our 
previous study (Skinner et al 2006). Thus, the Affymetrix 
microarrays allowed us to identify additional undescribed 
scrapie-associated gene expression alterations.
Several published TSE gene expression studies have 
sought to identify alterations in gene expression that occur 
in the brain. However, given the importance of the lymphoid 
organs in prion disease transmission and pathogenesis, there 
is a need to expand gene expression studies to the lymphoid 
organs. Another goal of the study presented here was to 
determine in scrapie-infected mice whether genes that show 
expression alterations in the brain also show expression 
alterations in spleen tissues.
In this study we used Affymetrix microarrays and 
identiﬁ  ed 67 genes that show alterations in expression in 
the brains of scrapie-infected mice prior to the onset of 
clinical symptoms. We conﬁ  rmed a number of these gene 
expression alterations using quantitative reverse transcription 
polymerase chain reaction (qRT-PCR). With qRT-PCR we 
also determined the time-course of several of these changes. 
We also determined the time course of astrocytosis and PrPsc 
accumulation in mice used in these studies, and evaluated 
protein accumulation of two genes identiﬁ  ed GFAP and Gh 
within the pituitary gland. In addition, we identiﬁ  ed 15 genes 
that showed alterations in gene expression in both spleen 
and brain tissues from scrapie-infected mice. We further 
evaluated protein accumulation and localization of one of 
these genes, anp32a, within the spleen. Our results extend 
our understanding of prion disease pathogenesis and indicate 
certain gene products that may serve as surrogate markers 
for early disease diagnosis.
Methods
Scrapie-infected mice
Three strains of mouse scrapie were examined: ME7, 22L, 
and RML-Chandler (Chandler 1963; Zlotnik and Rennie 
1963; Dickinson 1976). For Affymetrix microarray analyses, 
we used RNA isolated by the Chesebro lab and shipped to 
the Skinner lab, from ﬁ  ve male C57BL/10 mice that were 
infected with 50 μl of a 1% scrapie brain homogenate derived 
from mice at the end stage of scrapie infection. The titer of 
each inoculum was at least 2 × 108 infectious units/gram brain 
and exceeded the amount needed to induce disease in 100% 
of the animals (Vorberg et al 2004). RNA was from the same 
mice used in our previous study (Skinner et al 2006). This 
included RNA from two mock-infected mice and one ME7-
infected, one 22L-infected, and one RML-Chandler-infected 
mouse, sacriﬁ  ced at 104 days post-inoculation (dpi).
For the real-time PCR studies a separate set of female 
C57BL/6 mice was used. For each strain, six C57BL/6 
female mice were inoculated intracerebrally with 50 μl of a 
1% scrapie brain homogenate derived from mice at the end 
stage of scrapie infection. The titer of each inoculum was at 
least 2 × 108 infectious units/gram brain and exceeded the 
amount needed to induce disease in 100% of the animals 
(Vorberg et al 2004). Six control mice were mock-inoculated 
with 1% homogenate of brain tissues from uninfected mice. 
Mock-infected mice served as a control for nonspeciﬁ  c effects 
induced by the intracerebral injection of brain inoculum. 
At 46 and 104 dpi (before the onset of clinical symptoms), 
and at the onset of clinical symptoms at 144 dpi, two mice 
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from each group were sacriﬁ  ced. Mock- and scrapie-infected 
mice were sacrificed at the same time of day. Clinical 
symptoms included kyphosis, dull eyes, ﬂ  attened stature, 
weight loss, and ataxia. Total RNA was extracted from 
whole brain and spleen homogenates using Trizol following 
the manufacturer’s instructions (Invitrogen), resuspended 
in 100 μl of RNase free molecular biology grade water 
(Eppendorf), analyzed by spectrometry and gel electropho-
resis for quantity and quality, diluted to 1 μg/μl, and stored 
at −80 °C.
For the western blot analysis nine female C57BL/6 mice 
were infected with RML-Chandler strain of scrapie and nine 
mice were mock-infected as described above and three from 
each group sacriﬁ  ced at 45, 100, and 140 dpi.
For the immunohistochemistry staining of GFAP and 
Gh, one ME7, 22L, RML-Chandler, and one mock-infected 
C57BL/6 female mouse was infected and sacriﬁ  ced at 45, 
100, and 140 dpi. For anp32a immunohistochemistry three 
mice were infected with RML-Chandler, and three mock-
infected as described above and sacriﬁ  ced at 45 dpi.
Affymetrix microarrays
Total whole brain RNA from scrapie- and mock-infected 
mice sacrificed at 104 dpi was reverse transcribed and 
labeled following protocols provided by Affymetrix. Five 
Affymetrix Murine 430A chips were hybridized with RNA 
from two different mock-infected mice and RNA from one 
ME7-, one 22L-, and one RML-Chandler-infected mouse, 
following the manufacturer’s instructions. Scan intensity 
data was extracted and normalized from the Affymetrix out-
put ﬁ  les using the RMAExpress program (http://www.stat.
berkeley.edu/∼bolstad/RMAExpress/RMAExpress.html). 
MatchMiner (http://discover.nci.nih.gov/matchminer/index.
jsp) was used to convert Affymetrix IDs to corresponding 
GenBank accession numbers.
Statistical analyses and data mining
We used signiﬁ  cance of analysis of microarrays (SAM) with 
false discovery rates (FDR) and q-values to identify genes 
that showed differences in expression in scrapie-infected 
brains compared to mock-infected brains (Tusher et al 2001; 
Storey 2002). We performed a two-class test between results 
obtained from mock-infected mice and scrapie-infected mice, 
with data input parameters kept at the default values. We 
considered for further study those resultant genes that showed 
a 1.4-fold or greater change in scrapie-infected compared 
to mock-infected mice and had a q-value of 10%. For 
simplicity of presentation here, in instances where a gene 
was represented by more that one Affymetrix probe set, we 
removed duplicates showing synonymous results.
To determine the function of the proteins encoded by 
genes showing scrapie-associated alterations in expres-
sion, we used published literature, the National Center for 
Biotechnology Information (NCBI), and the Source (Diehn 
et al 2003).
Quantitative real-time RT-PCR
For real-time qRT-PCR, we used total RNA from whole 
brains and spleens. We compared RNA from two mock-
infected mice to RNA from six scrapie-infected mice at 46, 
104, and 144 dpi. The six scrapie-infected mice included 
two ME7-, two 22L-, and two RML/Chandler-infected mice. 
RNA was treated with deoxyribonuclease I (Fermentas, Glen 
Burnie, MD) to remove genomic DNA contamination and 
reverse transcribed to cDNA using SuperScript III reverse 
transcriptase (Invitrogen, Carlsbad, CA). An M × 3000P qPCR 
machine (Stratagene, La Jolla, CA) and Platinum SYBR 
Green qPCR SuperMix-UDG kits (Invitrogen) were used 
following manufacturers’ instructions. PCR primers were 
designed using MacVector software (Accelrys Inc., San 
Diego, CA), and spanned introns. Samples that were not 
treated with reverse transcriptase were included as a negative 
control. We previously made a stock of normal mouse brain 
RNA, treated it with DNAse, reverse transcribed it to cDNA, 
and puriﬁ  ed and used it in each qPCR reaction as a standard 
to normalize results from experimental samples. The relative 
cDNA levels were calculated using the 2−ΔΔCT method (Livak 
and Schmittgen 2001). Actin was used as the reference gene 
using previously described primers (Lengacher et al 2004). 
PCR products were run on an agarose gel to verify the size 
of product. For each gene studied, a t-test was performed 
to verify the signiﬁ  cance of the results. The primers and 
annealing temperatures used, as well as product sizes, are 
indicated in Table 2. Fold change values of less than 1 were 
converted using the equation −1/fold change, for ease of 
interpretation.
Western blot analysis
To detect levels of PrPsc protein accumulation in the spleen 
and brain, 20% solutions of spleen and brain tissue were 
prepared in 0.01M TrisHCL pH 7.4, 0.005 M MgCl, treated 
with DNAse, and sonicated. Tissue lysates were mixed with 
an equal volume (1 ml) of 20% sarcosyl in 0.01 M Tris HCl 
pH 7.4 and spun in an ultracentrifuge for thirty minutes in a 
Beckman ultracentrifuge rotor Type 70.1 (Beckman Coulter, 
Fullerton, CA) at 5000 RPM. Supernatant were transferred 
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to a new tube and centrifuged at 55000 RPM for two hours. 
The resultant pellet was resuspended in 1 ml water, sonicated, 
and then treated with 100 μg/ml proteinase K for 1 hour at 
37 °C. Reactions were terminated with 3 mM PMSF. Samples 
were again be spun at 55000 rpm for one hour and pellets 
resuspended in 2 × western blot sample buffer, sonicated, 
and boiled prior to loading on gels. For detection of Prpc 
and anp32a, brain and spleen tissues were lysed in RIPA 
buffer (50 mM Tris HCl pH 8, 150 mM NaCl, 1% NP-40, 
and 0.5% sodium deoxycholate, 0.1% SDS) with protease 
inhibitors (Sigma P8340; Sigma, St. Louis, MO) and centri-
fuged at 12000 rpm for 20 minutes. BCA protein assay kit 
(Pierce Biotechnology, Rockford, IL) was used to determine 
protein concentrations of resultant supernatant. 6.25 mg/well 
of protein was loaded for the PrP blot and 12.5 mg/well was 
used for the anp32a blot. Samples were run using pre-cast 
polyacrylamide gels in Tris-glycine (4%–12% IM-6000 
Invitrogen) and transferred to PVDF membranes (Millipore, 
Billerica, MA). Blots were probed with antibodies against 
PrP (SAF-83 from Cayman Labs, or anp32a from AbCam) 
and then were stripped and re-probed with antibodies directed 
against Gapdh (Chemicon) and densitometry determined 
levels of protein accumulation between samples from scrapie-
infected and mock-infected mice. Levels of Gapdh were used 
to normalize each sample.
Immunohistochemistry
Mice were perfused and ﬁ  xed overnight at 4 °C with freshly 
made paraformaldehyde. For Gh and GFAP staining tissues 
were dehydrated in alcohol and parafﬁ  n embedded. Sections 
were treated with antigen retrieval reagent (Diva Decloaker; 
Biocare, Concord, CA) and then blocked in blocking sniper 
solution (Biocare) for one hour, and then stained with either 
GFAP antibodies and counter stained with hematoxylin and 
eosin, or anti-human Gh antibodies (Biomeda, Foster City, 
CA) (1:1000) and counter stained with hematoxylin using 
the Vectastain ABC Kit (Vector Labs, Burlingame, CA). For 
anp32a staining, after ﬁ  xation tissues were transferred to phos-
phate buffer solution (PBS) and stored at 4 °C. Tissues were 
cut into 50 μm thick sections using a vibratome and blocked 
with 2% normal goat serum in PBS containing 0.3% Triton-
X100, and then stained free ﬂ  oating in 1 ml solution of rabbit 
anti-anp32a (AbCam) diluted 1:400 and rat anti-mouse-B220 
antibodies (BD Pharmingen, San Diego, CA) diluted 1:200 
in block solution on a rocking platform over night at 4 °C. 
Sections were then washed three times for at least 20 minutes 
with PBS and then incubated with goat anti-rabbit Alexa 488 
(Invitrogen) diluted 1:1000 and goat anti-rat Cy3 diluted 
1:5000 (Jackson ImmunoResearch, West Grove, PA) and 
incubated overnight at 4 °C on a rocking platform. Finally sec-
tions were again washed then mounted with glycerol-gelatin 
(Sigma) containing 4 mg/ml n-proply gallate as a ﬂ  uorophore 
preservative, and analyzed using a confocal microscope.
Results
Affymetrix microarray analysis of brain 
gene expression in scrapie-infected mice
We used Affymetrix microarrays and identiﬁ  ed 67 genes that 
showed increased expression in the brains of scrapie-infected 
mice prior to the onset of clinical symptoms at 104 dpi (Table 
1). In this study, gene expression was determined in two 
mock and three scrapie-infected male C57BL/10 mice. The 
set of scrapie-infected mice included one mouse infected with 
scrapie strain ME7, one with scrapie strain RML-Chandler, 
and one with scrapie strain 22L in order to allow us to ﬁ  nd 
scrapie-associated gene expression alterations that occur 
regardless of strain. A number of the genes we identiﬁ  ed 
have previously been described in related studies of prion 
disease, primarily at the end stages of disease, and these are 
cited in Table 1 (Dormont et al 1981; Manuelidis et al 1987; 
Duguid et al 1988; Duguid and Dinauer 1990; Diedrich et al 
1993; Duguid and Trzepacz 1993; Williams et al 1994; Dan-
doy-Dron et al 1998; Baker et al 1999, 2002, 2004; Doh-ura 
et al 2000; Gayrard et al 2000; Kopacek et al 2000; Riemer 
et al 2000, 2004; Baker and Manuelidis 2003; Rangon et al 
2003; Zhang et al 2003; Booth et al 2004a, 2004b; Brown 
et al 2004; Lu et al 2004; Schultz et al 2004; Xiang et al 2004; 
Viguie et al 2004; Greenwood et al 2005; Rodriguez et al 
2006; Skinner et al 2006). Eighteen of the genes we identiﬁ  ed 
have not been previously reported in prion disease studies 
(Table 1). The genes identiﬁ  ed function in multiple cellular 
processes including: immunity, the endosome lysosome 
system, the cytoskeleton, and hormone activity. Many of the 
genes function in multiple cellular processes, but are listed in 
a single functional category for ease of presentation.
Onset of pathology
In order to establish when pathological PrPsc accumula-
tion developed in the scrapie-infected mice, we performed 
western blot analysis of brain and spleen extracts from three 
mice infected with RML-Chandler strain of scrapie and three 
mock-infected mice at 45, 100, and 140 dpi. In the brain, PrPc 
was readily detectible at all time points examined. No protein-
ase K resistant PrPsc was detectible at 45 dpi, but was readily 
detectible at 100 and 140 dpi (Figure 1). This correlated 
with detection of increased GFAP immunoreactivity in 
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Table 1 Scrapie-associated expression alterations in brain at 104 dpi using Affymetrix microarrays
Function Gene symbol Fold change Previous references
Immunity B2m 2.4 Diedrich et al 1993; Dandoy-Dron et al 1994; Riemer et al 2000; Booth et al 2004a; 
Booth et al 2004b; Xiang et al 2004; Skinner et al 2006
Ccl12 1.6 Xiang et al 2004
Ccl9 1.4 Xiang et al 2004
Cxcl10 1.5 Baker et al 2004; Lu et al 2004; Riemer et al 2004; Schulz et al 2004; Xiang et al 2004;
C1qa 2.7 Klein et al 2001; Baker and Manuelidis 2003; Brown et al 2004; Riemer et al 2004; 
Xiang et al 2004; Skinner et al 2006
C1qb 3.7 Baker and Manuelidis 2003; Baker et al 2004; Brown et al 2004; Riemer et al 2004; 
Xiang et al 2004
C1qg 2.4 Riemer et al 2000; Riemer et al 2004; Xiang et al 2004
C4 2.6 Xiang et al 2004
Fcer1g 1.7 Baker and Manuelidis 2003; Booth et al 2004b; Xiang et al 2004
Fcgr2b 2.0 Baker and Manuelidis 2003; Xiang et al 2004
Fcgr3 1.5 Baker and Manuelidis 2003; Xiang et al 2004
Gbp4 1.4
Grn 1.6 Baker and Manuelidis 2003; Booth et al 2004b
H2-D1 2.2 Duguid and Trzepacz 1993; Riemer et al 2000; Booth et al 2004a; 
Riemer et al 2004; Xiang et al 2004 
H2-K1 1.7 Duguid and Trzepacz 1993; Riemer et al 2000; Booth et al 2004a; 
Riemer et al 2004; Xiang et al 2004 
H2-T23 1.6
Iﬁ  tm3 1.9
Iﬁ  t1 1.9  
Iﬁ  t3 2.8 Booth et al 2004b
Iﬁ  27 1.8
Ly86 2.5 Baker et al 2004; Booth et al 2004b; Lu et al 2004; 
Riemer et al 2004; Xiang et al 2004
Lyzs 1.9 Kopacek et al 2000; Xiang et al 2004
Rtp4 1.9
Lysosome Hexb 2.0 Kopacek et al 2000; Xiang et al 2004; Skinner et al 2006
Ctsc 1.6 Riemer et al 2004; Xiang et al 2004
Ctsh 1.5 Baker and Manuelidis 2003; Riemer et al 2004; Xiang et al 2004
Ctsl 1.4 Baker and Manuelidis 2003; Zhang et al 2003; Brown et al 2004; Lu et al 2004
Ctss 2.2 Baker et al 1999; Baker et al 2002; Baker and Manuelidis 2003; 
Baker et al 2004; Booth et al 2004b; Brown et al 2004; 
Riemer et al 2004; Xiang et al 2004; Lu et al 2004 
Ctsz 2.0 Riemer et al 2004; Xiang et al 2004
Cd68 1.8 Williams et al 1994; Baker et al 2002; Baker and Manuelidis 2003; 
Lu et al 2004; Riemer et al 2004; Xiang et al 2004
Laptm5 1.6 Riemer et al 2000; Booth et al 2004b; Riemer et al 2004; Xiang et al 2004 
Prdx6 1.4 Kopacek et al 2000
Hormone activity Cga 1.5
Gh 21.5 Viguie et al 2004
Prl 15.0
Pomc1 2.4 Gayard et al 2000
Cytoskeleton Aif1 1.6 Xiang et al 2004
Cnn3 1.5 Booth et al 2004b; Xiang et al 2004
(continued)
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astrocytes throughout the brain in mice infected with Me7, 
22L, and RML-Chandler strains of scrapie at 104 and 146 dpi 
(Appendix 2). In addition, our western blot analysis of PrPc 
and PrPsc in spleen tissues from the same scrapie-infected 
mice revealed that the proteinase K digestion was incomplete, 
but nonetheless showed abundant PrPc and PrPsc at 45, 100, 
and 140 dpi (data not shown).
qRT-PCR conﬁ  rmation of microarray 
results
We used quantitative RT-PCR (qRT-PCR) to conﬁ  rm a subset 
of the scrapie-associated alterations in expression of the genes 
identiﬁ  ed in our Affymetrix study that have not previously been 
described in association with TSEs, and to determine the time 
course over which these alterations occur. Twelve genes were 
selected that were representative of each functional category 
of genes identiﬁ  ed in the Affymetrix microarray study: immu-
nity, lysosome, ubiquitin/proteosome, and other. The genes 
evaluated were Usp18, Olfml3, Iﬁ  t1, Iﬁ  t3, Iﬁ  tm3, Iﬁ  t27, Rtp4, 
Stat1, Trem2, Grn, H2-T2, and Anp32a. Hormone genes were 
also evaluated and discussed in the next section. We evaluated 
gene expression in at three time points post-infection: prior 
to the onset of clinical symptoms (at 44 and 104 dpi) and at 
the time when symptoms became detectable (at 144 dpi). 
Table 1 (continued)
Function Gene symbol Fold change Previous references
Gfap 3.9 Dormont et al 1981; Wietgrefe et al 1985; Diedrich et al 1987; Manuelidis et al 1987; 
Duguid et al 1988; Campbell et al 1994; Baker et al 1999; Doh-ura et al 2000; 
Riemer et al 2000; Klein et al 2001; Baker et al 2002; Baker et al 2004; 
Brown et al 2004; Xiang et al 2004; Skinner et al 2006
Vim 2.0 Booth et al 2004a; Booth et al 2004b; Brown et al 2004; 
Riemer et al 2000; Xiang et al 2004
Protease Inhibitor Cst7 2.2 Baker and Manuelidis 2003; Lu et al 2004; Riemer et al 2004; Xiang et al 2004
Serpina3n 2.5 Riemer et al 2004; Xiang et al 2004
Calcium Anxa3 1.4 Riemer et al 2004
S100a6 1.5 Riemer et al 2004; Xiang et al 2004; Greenwood et al 2005
Scavenger receptor 
activity
Lgals3bp 2.5 Riemer et al 2004; Xiang et al 2004; Skinner et al 2006
Msr2 1.5 Xiang et al 2004
Ubiquitin/Proteosome Trim30 1.5 Xiang et al 2004
Usp18 1.6
Zinc Binding Mt2 1.6 Duguid et al 1988; Dandoy-Dron et al 1994; Riemer et al 2000; Xiang et al 2004
Pdlim4 1.4
Other Anp32a 1.6
Aqp4 1.8 Riemer et al 2000; Riemer et al 2004; Rodriguez et al 2006
Cd52 1.5 Riemer et al 2004; Xiang et al 2004
Cd53 1.6 Riemer et al 2004; Xiang et al 2004
Cd9 1.7 Doh-ura et al 2000; Brown et al 2004; Riemer et al 2004; Xiang et al 2004
Clecsf12 1.8 Xiang et al 2004
Cyba 1.6 Baker and Manuelidis 2003; Riemer et al 2004; Xiang et al 2004
Cyp7b1 1.5
Dbp 1.4
Hba-a1 1.4 Booth et al 2004b
Olfml3 1.6
Ppp1r3c 1.4
Prg1 1.4
Pycard 1.6 Xiang et al 2004
Stat1 1.8
Trem2 1.6
Tyrobp 2.3 Riemer et al 2004; Xiang et al 2004
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These time points were selected because they are similar to 
as those used in our previous study (Skinner et al 2006), and 
thus allow the two studies to be correlated. Gene expression 
levels were determined at each time point in two mock-infected 
and six scrapie-infected female C57BL/6 mice. The set of 
scrapie-infected mice included two infected with strain ME7, 
two with strain 22L, and two with strain RML-Chandler. As 
controls in this study, we used two genes: Atp1b1, because it 
showed decreased expression and GFAP, because it showed 
increased expression in the brains of scrapie-infected mice in 
our previous studies (Skinner et al 2006). Primers, annealing 
temperatures, and product sizes are presented in Table 2. We 
show the average expression from all three strains of scrapie-
infected mice relative to mock-infected mice in Table 3, and 
we present in Appendix 1 our more detailed results for each 
scrapie strain: ME7, 22L, and RML-Chandler. In this study, 
none of the genes showed signiﬁ  cantly altered expression at 
46 dpi. Five of the 12 genes showed signiﬁ  cantly increased 
expression at 104 dpi. These genes were Usp18, Olfml3, 
Iﬁ  t1, Iﬁ  t3, and Iﬁ  27. At the onset of clinical symptoms (144 
dpi), 11 of the 12 genes (all but Anp23a) showed signiﬁ  cant 
increased expression in the brain of scrapie-infected mice rela-
tive to mock-infected mice. Overall, although not statistically 
signiﬁ  cant in every case, all 12 experimental genes showed 
higher expression in scrapie-infected mice compared to mock-
infected mice at some point in time. Although none of the 
experimental genes showed signiﬁ  cant alteration in the brain 
at the very early time point 46 dpi, interestingly, the control 
gene Atp1b1 showed signiﬁ  cantly decreased expression at 
46 dpi, demonstrating that alterations in Atp1b1 occur very 
early in the course of scrapie infection.
Alterations in hormone expression 
in scrapie-infected mice
Four of the genes that showed increased expression in the brain 
of scrapie-infected mice prior to the onset of clinical symptoms 
encode hormones expressed primarily in the pituitary gland. 
These genes were Cga, Gh, Prl, and Pomc1. To conﬁ  rm these 
increases and to determine the time course over which these 
increases in hormone expression take place, we performed 
qRT-PCR and evaluated gene expression in scrapie-infected 
and mock-infected mice at 46, 104, and 144 dpi. Results shown 
in Table 4 depict the average of all three scrapie strains. Results 
from individual strains are presented in Appendix 1. Gh 
showed signiﬁ  cant increased expression at the very early time 
point 46 dpi. Gh, Prl, and Pomc1 showed increased expression 
at 104 and 144 dpi. In this study, Cga did not show signiﬁ  cant 
increased expression at any time point using qRT-PCR.
We then used qRT-PCR to determine whether the 
upstream regulators of these hormones might themselves 
be upregulated in scrapie-infected mice. We evaluated the 
expression of Crh, Ghrh, Trh, and Gnrh1, which induce the 
expression and secretion of hormones in the pituitary gland. 
None of these genes showed signiﬁ  cant expression alterations 
in presymptomatic mice. However, Crh showed increased 
expression at the onset of clinical symptoms (144 dpi) 
Figure 1 Prion protein and proteinase K resistant prion protein accumulation in brains from mock and RML-Chandler scrapie-infected mice at 45, 100, and 140 days post-infection. 
Western blot analysis showing prion protein antibody staining (SAF83) of protein extracts that were untreated or treated with proteinase K.
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Table 2 Primers and annealing temperatures used for qRT-PCR studies
Name Unigene No. Sequence T C Size
Prolactin-F
Prolactin-R
Mm.1270 5’- AACCTGCTGTTCTGCCAAAATG -3’
5’- TCTTGATAGGATGTATTCGGGGG -3’
60
60
369bp
Pomc1-F
Pomc1-R
Mm.277996 5’- GCCACTGAACATCTTTGTCCCC -3’
5’- ATCTCCGTTGCCAGGAAACAC -3’
60
60
296bp
Iﬁ  t3-F
Iﬁ  t3-R
Mm.271850 5’- TTCCCAGCAGCACAGAAAC -3’
5’- CCAGGTGAAATGGCACTTC-3’
60
60
96bp
Granulin-F
Granulin-R
Mm.1568 5’- CCTGCTTCCAGATGTCAGATAACC -3’
5’- TTCTTTAGTAGGGTGTGGGTGCC -3’
62
62
235bp
Anp32a-F
Anp32a-R
Mm.269088 5’- GAGCCGCTGAAGAAGTTAGAGAATC -3’
5’- GTTGTCCCTGTCATAGCCATCG -3’
60
60
138bp
Gh-F
Gh-R
Mm.343934 5’- TGGCAATGGCTACAGACTCTCG -3’
5’- TTAGAAAACAGACTGGACAAGGGC -3’
60
60
118bp
H2-T23-F
H2-T23-R
Mm.35016 5’- CAGAGTAACGACGAATCTCACACG -3’
5’- AGCCGTAGGTATCTATGGAGCCAC -3’
60
60
263bp
Rtp4-F
Rtp4-R
Mm.390891 5’- GGTTCCAGTGTTCCAGATGCTG -3’
5’- CCTGCGATTTCAAAGTGTCCG -3’
60
60
90bp
Iﬁ  27-F
Iﬁ  27-R
Mm.271275 5’- ACTCCAATCAGCAGGGGTCC -3’
5’- TTCTTTGACATCAGTGAGGGTTCTG -3’
60
60
193bp
Stat1-F
Stat1-R
Mm.277406 5’- GAGTGAGTGAGAGCCAGTCGTTTC -3’
5’- CCAAATGCTTCCGTTCCCAC -3’
62
62
171bp
Trem2-F
Trem2-R
Mm.261623 5’- TGGTGGAGGTGCTGGAGGAC -3’
5’- GGTGGGAAGGAGGTCTCTTGATTC -3’
62
62
133bp
Olfml 3-F
Olfml 3-R
Mm.211535 5’- TGCCTTAGAGGAACGGCTGG -3’
5’- TCCCTTTCAAGACGGTCCACTC -3’
60
60
174bp
Usp18-F
Usp18-R
Mm.326911 5’- CCTCGGTGATACCAAGGAACAG -3’
5’- TGTGAGTCATTGAAGCAGAACCAC -3’
60
60
144bp
Iﬁ  t1-F
Iﬁ  t1-R
Mm.6718 5’- GAGGAGTTCTGCTCTGCTGAAAAC -3’
5’- ACAGTTGCCCCAGGTCGC -3’
60
60
349bp
Atp1b1-F
Atp1b1-R
Mm.4550 5’- CTCGGAGAAGAAGGAGTTTTTGG -3’
5’- TCTGGGGAATCTGTGTCAATCC -3’
60
60
194bp
Gfap-F
Gfap-R
Mm.1239 5’- AGAAAACCGCATCACCATTCC -3’
5’- GCATCTCCACAGTCTTTACCACG -3’
60
60
128bp
Cga-F
Cga-R
Mm.1361 5’- ACACATCCCTCAAAAAGTCCAGAG -3’
5’- GAGAAGCAACAGCCCATACACTG -3’
60
60
223bp
Hexb-F
Hexb-R
Mm.27816 5’- GGGAGCGTTACGAGGTTTAGAGAC -3’
5’- TGAGGGAATCTTGGAGAATCAGC -3’
60
60
108bp
Ctsz-F
Ctsz-R
Mm.156919 5’- CCAAGGACCAAGACTGTGACAAG -3’
5’- CTGTTGCCATTATCCCGCAG -3’
60
60
183bp
Hspa4-R
Hspa4-F
Mm.239865 5’- GCTTGAGGTGGTTGGTCCG -3’
5’- ATACTGAAGAGCAGCAGCAGCC -3’
60
62
115bp
Hspa8-F
Hspa8-R
Mm.290774 5’- CGGGCATTCGTGTGGTCTC -3’
5’- CTTGGTGTGGTGCGGTTACC -3’
62
60
173bp
Hspa12-R
Hspa12-F
Mm.39739 5’- TGAACTGCTTGGCTGGTTGC -3’
5’- CAGGCTCTGAAGGAACTGAGTGAC -3’
62
62
109bp
Cd68-F
Cd68-R
Mm.15819 5’- ACAGGCAGCACAGTGGACATTC -3’
5’- GAGAGAGCAGGTCAAGGTGAACAG -3’
62
62
134bp
Actb-F
Actb -R
Mm.391967 5-GCTTCTTTGCAGCTCCTTCGT-3
5-ATATCGTCATCCATGGCGAAC-3
60
60
63bp
lﬁ  tm3 - F
lﬁ  tm3 - R
Mm.141021 5’- AGCCTATGCCTACTCCGTGAAGTC -3’
5’- TGAGGACCAAGGTGCTGATGTTC -3’
60
60
113 bp
Lhb-F
Lhb-R
Mm.57061 5’- GAGAGGCTCCAGGGGCTG -3’
5’- GCACAGGAGGCAAAGCAG -3’
60
60
214bp
(continued)
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Table 2 (Continued)
Name Unigene No Sequence T C Size
Tshb-F
Tshb-R
Mm.110730 5’- TCACTCATGCAAAGTAAGATCCTGC -3’
5’- GGCACACTCTCTCCTATCCACG -3’
60
60
218bp
Fshb-F
Fshb-R
Mm.249525 5’- GCTGACTGCACAGGACGTAG -3’
5’- CACCAGATCCCTAGTGTAGCAG -3’
60
60
209bp
Gnrh1-F
Gnrh1-R
Mm.358309 5’- TCACTCATGCAAAGTAAGATCCTGC -3’
5’- GGCACACTCTCTCCTATCCACG -3’
60
60
230bp
Trh-F
Trh-R
Mm.1363 5’- CCTGTGTATCCTATCCCAGTTCCC -3’
5’- CTGATTGGCTCTTTGAAGTTCCTG -3’
60
60
126bp
Crh-F
Crh-R
Mm.290689 5’- AAGGGAGGAGAAGAGAGCG -3’
5’- CAAGGCAGGCAGGACGAC -3’
60
60
92bp
Ghrh-F
Ghrh-R
Mm.144157 5’- AACTGTTCTCACCATCTAATCGGG -3’
5’- CCTTCACTCCTGGGTGGGACTC -3’
60
60
128bp
Cts S-F
Cts S-R
Mm.3619 5’-TGAGCACCACACTTCAGGATGACC-3’
5’-TCTTTTCCCAGATGAGACGCCG-3’
60
60
210bp
Notes: F and R refer to forward and reverse primers;   T °C is the annealing temperature used for qPCR.
(Table 4). We also determined whether other hormone genes 
that are primarily expressed in the pituitary gland were 
altered in pre-symptomatic scrapie-infected mice by evalu-
ating expression levels of Lhb, Tshb, and Fshb in scrapie- 
and mock-infected mice. These gene products bind to Cga 
(glycoprotein hormones alpha subunit) to form luteinizing 
hormone, thyroid-stimulating hormone, and follicle-stimulat-
ing hormone. None of these genes were signiﬁ  cantly altered 
in scrapie-infected mice (Table 4). These results conﬁ  rm 
the ﬁ  ndings from our Affymetrix microarray study, which 
showed increased expression of Gh, Prl, and Pomc1 in the 
brains of scrapie-infected mice. The results also show that not 
all hormone-encoding genes that are primarily expressed in 
the pituitary gland are altered in scrapie-infected mice. The 
increased expression of hormone genes identiﬁ  ed in our study 
is not likely due to increased expression of upstream regula-
tors of hormones but rather by some other mechanism.
Increases GFAP and Gh in anterior 
pituitary gland of scrapie-infected mice
Two of the genes that were found to be upregulated in scrapie-
infected mice were GFAP and Gh. We stained pituitary 
Table 3 Conﬁ  rmation of scrapie-associated gene expression alterations using qRT-PCR
Symbol Unigene No 46 dpi 104 dpi 144 dpi
AVE. FC p-value AVE. FC p-value AVE. FC p-value
Atp1b1 Mm.4550 −1.4 0.027 −1.3 0.013 −1.7 0.037
Usp18 Mm.326911 1.2 0.246 3.1 0.017 4.4 0.04
Gfap Mm.1239 1.2 0.138 2.4 0.019 10.1 0.006
Olfml3 Mm.211535 1 0.459 2.8 0.027 3.1 0.018
Iﬁ  t1 Mm.6718 1.2 0.386 2.2 0.028 4.9 0.019
Iﬁ  27 Mm.271275 1.1 0.356 2.7 0.036 2.9 0.021
Iﬁ  t3 Mm.271850 1.1 0.353 3.3 0.05 5.1 0.005
Rtp4 Mm.390891 1.3 0.573 1.2 0.416 5.4 0.007
Stat1 Mm.277406 1.3 0.531 1.2 0.275 2.4 0.01
Trem2 Mm.261623 1.6 0.131 1.3 0.227 4.3 0.012
Iﬁ  tm3 Mm.141021 1.2 0.284 1.2 0.343 3 0.014
Grn Mm.1568 1.1 0.395 1 0.398 3.1 0.019
H2-T23 Mm.35016 1.2 0.67 1.2 0.285 2.4 0.022
Anp32a Mm.269088 1.5 0.28 1.2 0.292 1.3 0.26
Notes: Statistically signiﬁ  cant expression alterations are highlighted in bold dpi is days post-infection;   AVE. FC is the average fold change in expression of scrapie samples 
relative to r.
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glands from ME7, 22L, and RML Chandler-infected mice and 
mock-infected mice at 45, 100, and 145 dpi with GFAP and 
Gh antibodies. Interestingly, both GFAP and Gh antibodies 
showed increased immunoreactivity in glandular hormone 
secreting cells of the anterior pituitary gland (Figures 2 and 3).
Alterations in gene expression 
in the spleen of scrapie-infected mice
Experimental intracerebral scrapie inoculation leads to 
the rapid accumulation of infectivity and PrPsc in second-
ary lymphoid organs including the spleen (Fraser and 
Dickinson 1970; Hunter et al 1972). To analyze gene 
expression in the spleen of scrapie-infected mice, we used 
qRT-PCR to evaluate relative expression levels of 22 genes 
that in our current or previous microarray studies (Skinner 
et al 2006) showed scrapie-associated expression altera-
tions in the brain. These genes were selected 1) because 
they encode proteins that function either in protein folding 
or in the endosome/lysosome system (where misfolded 
prion proteins accumulate), 2) because they function in 
Figure 2 GFAP antibody staining in the anterior pituitary gland (adenohypophysis) from scrapie- and mock-infected mice at 45, 100, and 140 days post-infection. Sections were 
stained with GFAP antibodies (brown) and counterstained with hematoxylin (blue) and eosin (pink). Images were collected with 20 × and 60 × objectives as indicated. Note 
increased GFAP immunoreactivity in glandular cells of anterior pituitary in sections from scrapie-infected mice relative to mock-infected mice.
Table 4 Hormone and hormone regulator gene expression in scrapie-infected vs mock-infected mice using qRT-PCR
46 dpi 104 dpi 144 dpi
Gene Symbol Unigene No AVE. FC p-value AVE. FC p-value AVE. FC p-value
Gh Mm.343934 1.5 0.012 14 0.015 13.9 0.014
Prl Mm.1270 1.4 0.508 13.5 0.007 14.8 0.014
Pomc1 Mm.277996 1.1 0.379 5.1 0.03 5.3 0.015
Crh Mm.290689 1.2 0.582 −1.4 0.213 2.8 0.026
Cga Mm.1361 1.3 0.786 1 0.377 1.5 0.169
Tshb Mm.110730 1.3 0.813 1.6 0.138 1 0.459
Lhb Mm.57061 1.3 0.431 1.4 0.232 1.5 0.183
Ghrh Mn.144157 1.5 0.394 1.3 0.27 1.1 0.106
Trh Mm.1363 1 0.541 −1.3 0.274 2.7 0.157
Fshb Mm.249525 1 0.486 1 0.302 1.1 0.453
Gnrh1 Mm.358309 1.4 0.512 1 0.358 1.4 0.236
Notes: Statistically signiﬁ  cant expression alterations are highlighted in bold dpi is days post-infection;   AVE. FC is the average fold change in expression detected in scrapie 
samples relative to mock samples.
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immunity (a major functional group of genes that show 
altered expression in the brain during prion disease), or 
3) because they were novel genes that have never been 
described in association with prion diseases. These genes 
were Hspa8, Hspa12a, Hspa4, Ctsz, Ctss, HexB, H2-T23, 
Iﬁ  t1, Iﬁ  t3, Iﬁ  tm3, Iﬁ  27, Rtp4, Cd68, Gh, Grn, Stat1, Usp18, 
Trem2, Olfml3, and Anp32a. We also included GFAP 
and Atp1b1 because in our previous studies they showed 
increased and decreased expression, respectively, in the 
brain early in the course of scrapie infection (Skinner et al 
2006). We evaluated gene expression in the spleen at the 
same time points as in our brain studies: at two time points 
prior to the onset of clinical symptoms (at 46 and 104 dpi) 
and at the time when clinical symptoms appeared in the 
mice (at 144 dpi).
The results showed that all 22 genes evaluated 
were expressed in the spleen. At 46 dpi, two of the 
22 genes – Anp32a and Grn – showed signiﬁ  cant increases in 
expression in the spleens of scrapie-infected mice compared 
to mock-infected mice (Table 5). These two genes also 
showed signiﬁ  cantly increased expression at the later time 
points, 104 and 144 dpi. At 104 dpi, in addition to Anp32a 
and Grn, 12 other genes showed signiﬁ  cantly increased 
expression relative to mock-infected mice. These genes 
were Ctsz, HexB, Ctss, Hspa4, Hspa8, Hspa12a, Iﬁ  t1, Iﬁ  t3, 
Iﬁ  tm3, Cd68, Iﬁ  27, and Olfml3 (Table 5). At the onset of 
clinical symptoms, at 144 dpi, these 14 genes continued to 
show signiﬁ  cant increased levels of expression, and were 
joined by H2-T23 (Table 5). The remaining genes, Gh, Stat1, 
Usp18, Rtp4, Gfap, Trem2, and Atp1b1, were expressed in 
the spleen, but none showed signiﬁ  cantly altered expression 
at any time point (Table 5). Table 5 shows the results from 
averaging the expression of all three scrapie strains relative 
to mock-infected mice. Appendix 3 shows results obtained 
for each strain individually. These results demonstrate that 
prior to the onset of clinical symptoms, scrapie induces 
multiple alterations in gene expression that occur in both 
the spleen and brain.
In order to determine if anp32a which showed very early 
increased expression in spleens of scrapie-infected mice also 
showed increased protein accumulation in the spleen or brain 
of scrapie-infected mice, we performed western blot analysis 
using brains and spleens from three mice infected with RML/
Chandler strain of scrapie and three mock-infected mice 
sacriﬁ  ced at 100 dpi. As shown in ure 4, we found anp32a 
protein accumulated 3.7 times more in spleens from scrapie-
infected mice compared to mock-infected mice (p = 0.03). In 
the brain, anp32a showed 1.5 times more anp32a protein in 
scrapie-infected compared to mock-infected mice, but this 
trend was not signiﬁ  cant (p = 0.1).
In order to localize anp32a protein expression within the 
spleen of scrapie-infected mice, we stained spleen sections 
Figure 3 Growth hormone (Gh) antibody staining in the anterior pituitary gland (adenohypophysis) from scrapie- and mock-infected mice at 45, 100, and 140 days post-infection. 
Images show sections stained with Gh antibodies (brown) and counterstained with haematoxylin (blue). Images were collected with 20 × and 60 × objectives as indicated. Note 
increased Gh immunoreactivity in glandular cells of anterior pituitary in sections from scrapie-infected mice relative to mock-infected mice.
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from RML/Chandler scrapie-infected mice with antibodies 
directed against anp32a and the B cell marker B220. 
The results showed that anp32a was expressed in B cells as 
well as other cell types (Figure 4C)
Discussion
These studies shed light on the complex molecular events 
that occur during prion disease and identify genes whose 
further study may yield new insights into TSE pathogenesis 
and transmission. We identiﬁ  ed 67 genes that show altered 
expression in the brain and 15 genes that show altered expres-
sion in both the spleen and brain of scrapie-infected mice. 
All of the scrapie-associated alterations in gene expression 
in the brain, and 14 out of 15 in the spleen, occurred prior 
to the development of clinical symptoms and therefore may 
lead to the development of ante-mortem tests for TSEs.
Fourteen genes showed increased expression in the 
spleens of scrapie-infected mice prior to the onset of clinical 
symptoms. These same genes showed increased expression in 
the brains of scrapie infected mice as presented here or in our 
previous studies (Skinner et al 2006). Because these increases 
in gene expression occur in both the brain and the spleen prior 
to the onset of disease, and because prion infectivity and PrPsc 
accumulates in both the spleen and brain of scrapie infected 
mice, these genes may be important contributors to the 
mechanism by which prion proteins misfold and accumulate 
and to the dissemination of TSE infectivity.
Importantly, all seven of the genes evaluated in the spleen 
that function in protein folding or in the endosome/lysosome 
system showed increased expression in scrapie-infected mice 
relative to mock-infected mice. These genes were Hspa8, 
Hspa4, Hspa12a, Cd68, Ctsz, Ctss, and HexB. These results 
support our hypothesis that genes that function in protein 
folding or in the endosome/lysosome system contribute to 
prion disease pathogenesis and are important cofactors in 
the misfolding and accumulation if prion proteins. Most of 
the genes involved in immunity also showed alterations in 
expression in the spleens of scrapie-infected mice. These 
genes were Grn, Iﬁ  t1, Iﬁ  t3, ﬁ  tm3, Iﬁ  27, and H2-T23. In 
addition, Anp32a, which functions in signal transduction, and 
Table 5 Spleen gene expression in scrapie-infected vs mock-infected mice at 46, 104, and 144 dpi
46dpi 104dpi 146dpi
Symbol Unigene No AVE. FC p-value AVE. FC p-value AVE. FC p-value
Grn Mm.1568 2.2 0.03 2.5 0.009 1.7 0.027
Anp32a Mm.269088 2.2 0.011 1.7 0.037 2.4 0.03
Hspa8 Mm.290774 1.9 0.382 2.6 0.028 1.7 0.029
Olfml3 Mm.211535 1.6 0.396 2.5 0.011 2.3 0.039
Iﬁ  t1 Mm.6718 1.9 0.37 2.1 0.045 1.9 0.019
Iﬁ  t3 Mm.271850 2.7 0.196 2.1 0.004 1.8 0.039
Hspa12a Mm.39739 1.5 0.343 2 0.042 2 0.016
Iﬁ  tm3 Mm.141021 1.6 0.18 2 0.015 2 0.01
Cd68 Mm.15819 1.6 0.158 1.9 0.021 2 0.023
Iﬁ  27 Mm.271275 1.6 0.419 1.7 0.029 1.7 0.029
Hspa4 Mm.239865 2.3 0.109 1.6 0.024 1.8 0.021
Ctsz Mm.156919 2.5 0.091 1.6 0.027 1.9 0.024
HexB Mm.27816 1.6 0.405 1.6 0.016 1.8 0.018
Ctss Mm.3619 2.1 0.175 1.6 0.039 1.7 0.024
H2-T23 Mm.35016 1.8 0.036 1.2 0.303 1.8 0.036
Gh Mm.343934 1.4 0.262 1.3 0.206 2 0.061
Stat1 Mm.277406 1.4 0.126 1.5 0.28 1.4 0.262
Usp18 Mm.326911 1.2 0.348 1.9 0.159 1.4 0.126
Rtp4 Mm.390891 1.1 0.832 1 0.442 1.2 0.348
Gfap Mm.1239 1.1 0.362 1.5 0.28 1.1 0.832
Trem2 Mm.261623 −1.3 0.211 1.4 0.293 1.1 0.362
Atp1b1 Mm.009721 1.1 0.702 −1.1 0.293 −1.3 0.211
Notes: Statistically signiﬁ  cant expression alterations are highlighted in bold.   All genes presented here showed expression in the spleen in this study dpi is days post infection. 
AVE. FC is the average expression of scrapie samples/mock samples.
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Olfml3, a gene of unknown function, were also found to show 
increased expression in spleens of scrapie-infected compared 
to mock-infected mice. Gene alterations in the spleen may 
prove useful as markers for the preclinical diagnosis of prion 
diseases. It will be particularly important to identify which 
cell types alterations occur in and whether these alterations 
also occur in cells in the blood.
Some genes differ with regard to the time post-
infection at which altered expression was ﬁ  rst observed in 
the spleen compared to brain. Grn and Anp32a showed 
increased expression in the spleen at 46 dpi, but did not 
show altered expression in the brain until 104 dpi. Gh 
showed increased expression, and Atb1b1 showed decreased 
expression in the brains of scrapie-infected mice at 46, 104, 
and 144 dpi, but neither showed signiﬁ  cant alterations in 
expression at any of these time points in the spleen. Olfml3 
and Iﬁ  t1 showed altered expression at 104 dpi in both brain 
and spleen tissues. These similarities and differences in the 
time course of alterations between the spleen and brain tissues 
might be attributed to similar and different pathological 
changes that are occurring in each of these tissue compart-
ments during the course of disease.
It is unclear why there was a delay in detection upregu-
lated genes in our qRT-PCR study relative to our microarray 
study, but may be due to differences in the sex and stains 
of mice used in the studies. A set of male C57BL/10 mice 
was used for the microarray studies, and a different set of 
female C57BL/6 mice was used for the qRT-PCR studies. 
Differences may also be due to small sample numbers. Impor-
tantly, because our qRT-PCR results did show that 11 of 
12 genes examined showed signiﬁ  cant increased expression 
at 146 dpi, these results conﬁ  rm that these 11 genes show 
scrapie-associated expression alterations and validate the 
microarray results.
Very little is known about the molecular changes that take 
place very early after TSE infection. Four genes in this study 
showed altered expression at the very early time point, 46 dpi. 
In the brain, we observed signiﬁ  cantly decreased expression 
Figure 4 Anp32a protein accumulation in brain and spleen of scrapie-and mock-infected mice. A) Western blot results from three mock and three scrapie-infected mice at 
100 days post-infection stained with anp32a antibodies, and stripped and reprobed with Gapdh antibodies. B) Densitometry analysis of western blot results showing relative 
amounts of anp32a accumulation in scrapie verses mock-infected mice. C) Anp32a (green) and B220 (red) antibody staining in spleen tissue from scrapie-infected mouse. 
Note: B220 is a B cell marker.
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of ATPase Na+/K+ transporting beta 1 polypeptide (Atp1b1) 
and increased expression in Gh. In the spleen acidic leucine-
rich nuclear phosphoprotein 32 family member A (Anp32a) 
and granulin (Grn) showed signiﬁ  cant increased expression. 
Atb1b1 is an intrinsic membrane protein that functions in the 
active transport of Na+ and K+ ions in most animal cells, is 
important for transmission of action potentials in neurons, 
and also is associated with caveolae and intracellular signal 
transduction events (Kaplan 2002; Liu and Askari 2006). Gh, 
in addition to stimulating growth, also functions in an auto-
crine and paracrine fashion in reproduction processes, immu-
nity, tooth development, retinal development, and placental 
function (Harvey et al 2003; Harvey and Hull 2003). Anp32a 
is thought to function in signal transduction and interacts with 
the cytoskeleton (Opal et al 2003; Matilla and Radrizzani 
2005), and has been implicated in other neurodegenerative 
diseases. For example, its expression is decreased in spino-
cerebellar ataxia type 3 (Evert et al 2003), and it binds to 
and colocalizes with mutant ataxin-1, the protein that causes 
spinocerebellar ataxia type 1 (Matilla et al 1997). Full length 
Grn gets processed into a variety of 6 kDa peptides and full 
length protein and peptides are important for, regulation 
of cell growth, normal development, wound healing, and 
tumorigenesis. Interestingly, mutations in Grn have recently 
been discovered to cause frontotemporal dementia linked 
to chromosome 17 (FTD-17) (Baker et al 2006; Cruts et al 
2006; Mukherjee et al 2006). Additional studies are needed 
to expand our understanding of the contributions to TSE 
disease pathogenesis and progression of Gh, Atp1b1, Anp32a 
and Grn, as well as the other scrapie-induced alterations in 
gene expression identiﬁ  ed in this study that occur later in the 
progression of the disease. In addition, we evaluated only 
22 genes at the very early time-point 46 days post-infection. 
Additional large scale microarray studies of tissues from 
scrapie-infected compared to mock-infected mice at very 
early time-points post infection are warranted.
Our studies also found that the pituitary hormones pro-
lactin (Prl), Gh, and pro-opiomelanocortin-alpha (Pomc1) 
showed increased expression in the brains of scrapie-infected 
mice prior to the development of clinical symptoms. Pomc1 
encodes a 235 amino acid protein that gets processed to 
produce at least eight peptides including: adrenocorti-
cotropic hormone (ACTH), lipotropins, endorphins, and 
melanocyte-stimulating hormones (MSHs). The scrapie-
associated upregulation of these genes was not associated 
with a concurrent increase in the expression in upstream 
regulators of these hormones, Crh, Gnrh1, Trh, and Ghrh, 
indicating that some other mechanism is responsible for 
the upregulation pituitary hormones identiﬁ  ed in our study. 
Previous studies in hamsters showed that scrapie strain 
139H, but not strain 263K, highly impacts the pituitary 
gland, inducing neuropathology including vacuolization, 
atrophy, cytoplasmic vesicles, and hypertrophy (Ye and 
Carp 1996). This neuropathology in the pituitary gland is 
associated with hyperplasia and hypertrophy of islets of 
Langerhan cells, thyroid glands, adrenal glands, liver, and 
kidneys (Ye and Carp 1996). In addition, increased plasma 
levels of Gh, ACTH, and cortisol are evident during natural 
sheep scrapie (Gayrard et al 2000; Viguie et al 2004). Taken 
together, these studies indicate that alterations in the expres-
sion of pituitary hormones may be responsible for some of 
the clinical symptoms observed during scrapie infection in 
mice, hamsters, and sheep.
This study identiﬁ  ed alterations in gene expression that 
occur in three strains of scrapie in mice. Mice infected 
intracerebrally with the scrapie strains ME7, 22L and RML-
Chandler differ in incubation period, in neuropathology, 
and in disease associated alterations in gene expression 
(Dickinson 1976; Bruce and Fraser 1991; Kascsak et al 
1991; Booth et al 2004a; Skinner et al 2006). Alterations 
that occur regardless of strain and in multiple TSEs are 
more likely to play a critical role in TSE pathogenesis and 
disease progression, whereas alterations in gene expression 
that do not occur in all TSEs or in only some strains are more 
likely to be associated with strain-speciﬁ  c neuropathological 
changes.
These studies show that as few as ﬁ  ve mice, two mock-
infected and three scrapie-infected (with scrapie strain ME7, 
22L, and RML-Chandler, respectively), are sufﬁ  cient to 
identify alterations in gene expression that occur during the 
course of scrapie infection in C57BL mice. Our analysis 
identiﬁ  ed 67 gene expression alterations in scrapie-infected 
mice relative to mock-infected mice. These alterations were 
veriﬁ  ed by the fact that 1) most of the genes identiﬁ  ed in our 
study have been described by us or others in related prion 
disease studies, 2) the novel gene alterations described here 
were conﬁ  rmed in the brain a separate set of scrapie-infected 
mice using qRT-PCR, and 3) several of these genes were 
also found to show signiﬁ  cant increased expression in spleen 
tissues from scrapie-infected mice relative to mock-infected 
mice. Thus, Affymetrix microarray studies using only ﬁ  ve 
mice can prove useful for the identiﬁ  cation of gene expres-
sion alterations in scrapie-infected mice. At the same time, 
the small sample size with the microarray study likely limited 
the total amount of gene alterations identiﬁ  ed. Additional 
studies with increased numbers of mice may yield more 
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genes that show signiﬁ  cant scrapie-associated changes in 
gene expression.
Although many of the genes identiﬁ  ed in this study 
showed relatively large (greater than two-fold) changes 
in expression relative to mock-infected mice, many other 
genes showed relatively low (less than two-fold) changes. 
Relatively low-fold changes in gene expression may lead 
to substantial effects in the brain that are important to prion 
disease pathogenesis. Also, because our studies used RNA 
from total brain tissue including multiple cell types from 
multiple regions of the brain, we anticipate that gene altera-
tions that occur in a single cell type or only in a particular 
region of the brain will show a low fold change in this 
analysis due to dilution by mRNA from surrounding cells 
or brain regions in which the particular gene alteration is 
not occurring. Thus, for gene expression analyses involving 
complex tissues such as brain, low fold changes in gene 
expression may indicate large fold changes in a subset of 
cells or cells in a particular region of the tissue and should 
not be overlooked.
Future studies are needed to determine whether the 
scrapie-associated alterations identiﬁ  ed in mice also occur 
in other animals and humans with TSEs, and whether the 
alterations are speciﬁ  c to prion disease. We also need to 
determine what the range is of normal variation in expression 
levels among individuals. To our knowledge, the decrease in 
erythroid differentiation-related factor (EDRF) expression is 
the only other nonneuronal alteration in gene expression that 
is associated with prion diseases described to date (Miele 
et al 2001). Decreased EDRF expression levels were found in 
spleen, bone marrow, and blood of scrapie-infected rodents, 
and were also found in tissues from BSE-infected cows and 
scrapie-infected sheep. As researchers attempted to translate 
these ﬁ  ndings to a diagnostic assay for human TSEs, they 
discovered that EDRF expression levels in blood are highly 
variable amongst individual humans, making it difﬁ  cult to 
use EDRF expression levels as a marker for disease (Glock 
et al 2003). We are hopeful that some of the genes identiﬁ  ed 
in this study that show scrapie-associated changes, will show 
similar disease-associated changes in humans and show low 
variability in expression between humans and thus be good 
surrogate markers for the early diagnosis of prion disease in 
humans and animals.
Conclusions
We identiﬁ  ed a set of genes that show altered expression 
prior to the onset of clinical symptoms in spleen and brain 
tissues from scrapie-infected mice. These studies take us 
several steps forward in our understanding of the molecular 
events underlying scrapie pathogenesis. Some of the genes 
identiﬁ  ed in this study may serve as surrogate markers for 
prion disease diagnosis and lead to the identiﬁ  cation of targets 
for drug therapies.
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Appendix 1 Brain gene expression in mice infected with ME7, 22L, and RML-Chandler strains of scrapie vs. mock-infected mice using 
qRT-PCR 
D.P.I. Gene symbol Unigene  RT -PCR fold change,  p-value,  and standard deviation
ME7 p-value SD RML p-value SD 22L p-value SD AVE. p-value SD
46 Gh Mm.343934 1.5 0.01 0.264 1.3 0.017 0.324 1.6 0.008 0.271 1.5 0.012 0.286
Atp1b1 Mm.4550 0.7 0.045 0.115 0.7 0.003 0.246 0.7 0.033 0.121 0.7 0.027 0.164
Gfap Mm.1239 1.2 0.142 0.115 1.2 0.153 0.074 1.2 0.119 0.042 1.2 0.138 0.077
Usp18 Mm.326911 1.3 0.047 0.343 1.2 0.289 0.455 1.1 0.402 0.336 1.2 0.246 0.378
Iﬁ  t3 Mm.271850 1.1 0.366 0.321 1.2 0.198 0.433 1.1 0.494 0.344 1.1 0.353 0.366
Iﬁ  27 Mm.271275 1.1 0.374 0.281 1.1 0.411 0.334 1.2 0.284 0.321 1.1 0.356 0.312
Pomc1 Mm.277996 1.2 0.24 0.164 1.1 0.46 0.243 1 0.436 0.343 1.1 0.379 0.250
Iﬁ  t1 Mm.6718 1.5 0.262 0.417 1 0.452 0.544 1.1 0.444 0.470 1.2 0.386 0.477
Olfml3 Mm.211535 1 0.496 0.457 1 0.436 0.392 1 0.444 0.363 1 0.459 0.404
Prl Mm.1270 1.4 0.657 0.464 1.4 0.296 0.430 1.3 0.572 0.544 1.4 0.508 0.479
Rtp4 Mm.390891 1.2 0.52 0.436 1.6 0.641 0.473 1.1 0.557 0.445 1.3 0.573 0.451
Trem2 Mm.261623 1.4 0.066 0.281 2.2 0.106 0.458 1.3 0.222 0.234 1.6 0.131 0.324
Grn Mm.1568 1.3 0.226 0.244 1 0.499 0.278 1 0.461 0.303 1.1 0.395 0.275
Iﬁ  tm3 Mm.141021 1.2 0.188 0.306 1.3 0.429 0.425 1.2 0.236 0.314 1.2 0.284 0.348
H2-T23 Mm.35016 1.1 0.667 0.316 1.3 0.569 0.347 1.1 0.773 0.450 1.2 0.67 0.371
Stat1 Mm.277406 1.4 0.305 0.249 1.1 0.69 0.201 1.3 0.599 0.252 1.3 0.531 0.234
Cga Mm.1361 1.3 0.786 0.343 1.4 0.737 0.219 1.4 0.715 0.255 1.4 0.746 0.272
Anp32a Mm.269088 1.6 0.476 0.268 1.4 0.28 0.342 1.4 0.085 0.320 1.5 0.28 0.310
Crh Mm.290689 0.9 0.786 0.173 1.3 0.373 0.238 1.3 0.588 0.211 1.2 0.582 0.207
Trh Mm.1363 0.9 0.585 0.324 1.1 0.464 0.207 1.2 0.572 0.308 1 0.541 0.280
Lhb Mm.57061 1.2 0.366 0.157 1.5 0.572 0.423 1.2 0.355 0.158 1.3 0.431 0.246
Gnrh1 Mm.358309 1.6 0.514 0.788 1.3 0.436 0.478 1.5 0.586 0.765 1.4 0.512 0.677
Fshb Mm.249525 1 0.488 0.198 1 0.492 0.352 1 0.48 0.489 1 0.486 0.347
Ghrh Mn.144157 1.4 0.443 0.393 1.6 0.27 0.440 1.6 0.468 0.285 1.5 0.394 0.373
Tshb Mm.110730 1.5 0.792 0.292 1.2 0.84 0.465 1.3 0.801 0.423 1.3 0.813 0.393
Actb Mm.391967 1.2 0.658 0.256 1.2 0.714 0.252 1.1 0.776 0.233 1.2 0.716 0.247
104 Gh Mm.343934 14.7 0 0.320 14.4 0.007 0.304 13 0.037 0.095 14 0.015 0.031
Atp1b1 Mm.4550 0.9 0.013 0.000 0.8 0.011 0.262 0.6 0.013 0.147 0.8 0.013 0.136
Gfap Mm.1239 2.4 0.002 0.318 2.3 0.02 0.318 2.6 0.035 0.286 2.4 0.019 0.281
Usp18 Mm.326911 2.8 0.005 0.075 2.9 0.037 0.156 3.5 0.007 0.257 3.1 0.017 0.027
Iﬁ  t3 Mm.271850 5.5 0.05 0.275 1.8 0.05 0.217 2.7 0.048 0.303 3.3 0.05 0.158
Iﬁ  27 Mm.271275 2.6 0.012 0.217 1.6 0.479 0.184 3.1 0.051 0.163 2.7 0.036 0.188
Pomc1 Mm.277996 4.7 0.031 0.360 5.2 0.025 0.283 5.4 0.035 0.266 5.1 0.03 0.303
Iﬁ  t1 Mm.6718 2.4 0.012 0.399 1.9 0.048 0.344 1.6 0.025 0.354 2.2 0.028 0.365
Olfml3 Mm.211535 1.8 0.03 0.137 2.9 0.038 0.177 3.5 0.012 0.219 2.8 0.027 0.178
Prl Mm.1270 13 0.013 0.264 14.5 0.004 0.248 13.1 0.004 0.293 13.5 0.007 0.268
Rtp4 Mm.390891 1.1 0.493 0.243 0.9 0.479 0.344 1.6 0.276 0.190 1.2 0.416 0.366
Trem2 Mm.261623 1.2 0.333 0.194 1.3 0.299 0.177 1.3 0.05 0.421 1.3 0.227 0.264
Grn Mm.1568 0.9 0.484 0.440 1.1 0.338 0.243 1.1 0.372 0.243 1 0.398 0.308
Iﬁ  tm3 Mm.141021 1.2 0.34 0.186 1 0.391 0.093 1.2 0.3 0.093 1.2 0.343 0.124
H2-T23 Mm.35016 1.1 0.274 0.238 1.1 0.376 0.118 1.5 0.205 0.289 1.2 0.285 0.215
Stat1 Mm.277406 1 0.452 0.246 1.2 0.247 0.381 1.4 0.125 0.377 1.2 0.275 0.280
Cga Mm.1361 1 0.438 0.115 1 0.258 0.140 1.1 0.434 0.201 1 0.377 0.152
Anp32a Mm.269088 1.3 0.015 0.185 1 0.434 0.114 1.3 0.296 0.382 1.2 0.292 0.227
Crh Mm.290689 0.8 0.465 0.343 0.7 0.072 0.197 0.8 0.103 0.160 0.7 0.213 0.233
(Continued)
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Appendix 1 (Continued)
D.P.I. Gene symbol Unigene  RT -PCR fold change,  p-value,  and standard deviation
ME7 p-value SD RML p-value SD 22L p-value SD AVE. p-value SD
Trh Mm.1363 0.8 0.4 0.168 0.8 0.292 0.276 0.7 0.129 0.247 0.8 0.274 0.230
Lhb Mm.57061 1.1 0.239 0.228 1.5 0.222 0.179 1.7 0.233 0.421 1.4 0.232 0.276
Gnrh1 Mm.358309 1 0.473 0.543 1 0.388 0.287 1 0.212 0.192 1 0.358 0.312
Fshb Mm.249525 1 0.338 0.374 1 0.284 0.223 1 0.284 0.312 1 0.302 0.303
Ghrh Mn.144157 1.4 0.141 0.200 1.2 0.242 0.125 1.4 0.425 0.386 1.3 0.27 0.237
Tshb Mm.110730 1.9 0.117 0.276 1 0.103 0.353 1.9 0.196 0.430 1.6 0.138 0.357
Actb Mm.391967 1 0.494 0.281 1.1 0.477 0.197 1.1 0.451 0.112 1.1 0.474 0.197
146 Gh Mm.343934 14.8 0.009 0.173 13.7 0.029 0.251 13.3 0.005 0.131 13.9 0.014 0.185
Atp1b1 Mm.4550 0.7 0.05 0.141 0.5 0.027 0.100 0.7 0.033 0.327 0.6 0.037 0.189
Gfap Mm.1239 9.3 0 0.140 6.4 0.018 0.169 14.5 0.001 0.162 10.1 0.006 0.157
Usp18 Mm.326911 4.8 0.03 0.268 3.2 0.04 0.253 5.2 0.05 0.122 4.4 0.04 0.215
Iﬁ  t3 Mm.271850 5.9 0 0.380 3.6 0.014 0.178 5.8 0.002 0.277 5.1 0.005 0.278
Iﬁ  27 Mm.271275 2.8 0.024 0.142 2.8 0.034 0.149 3.3 0.004 0.195 2.9 0.021 0.162
Pomc1 Mm.277996 6.8 0 0.145 3.7 0.009 0.353 5.4 0.036 0.188 5.3 0.015 0.229
Iﬁ  t1 Mm.6718 5.2 0 0.319 3.7 0.034 0.192 5.8 0.024 0.142 4.9 0.019 0.218
Olfml3 Mm.211535 2.7 0.012 0.256 2.3 0.042 0.171 4.4 0.001 0.387 3.1 0.018 0.271
Prl Mm.1270 17.1 0 0.424 11.6 0.014 0.129 15.8 0.027 0.234 14.8 0.014 0.262
Rtp4 Mm.390891 5.2 0.002 0.123 5.2 0.005 0.155 6 0.014 0.256 5.4 0.007 0.178
Trem2 Mm.261623 4.8 0 0.174 3.4 0.027 0.258 4.6 0.01 0.270 4.3 0.012 0.234
Grn Mm.1568 2.9 0.007 0.250 2.5 0.047 0.298 3.8 0.002 0.180 3.1 0.019 0.243
Iﬁ  tm3 Mm.141021 3.3 0.005 0.195 2.1 0.019 0.166 3.7 0.019 0.155 3 0.014 0.172
H2-T23 Mm.35016 2.1 0.018 0.148 1.9 0.042 0.175 3.2 0.006 0.112 2.4 0.022 0.145
Stat1 Mm.277406 2 0 0.033 1.8 0.001 0.044 3.3 0.028 0.049 2.4 0.01 0.042
Cga Mm.1361 2.8 0.069 0.596 1.6 0.281 0.421 1.6 0.157 0.308 1.5 0.169 0.442
Anp32a Mm.269088 1.2 0.259 0.110 1 0.483 0.157 1.8 0.039 0.147 1.3 0.26 0.138
Crh Mm.290689 3.4 0.023 0.202 2 0.037 0.141 3 0.017 0.133 2.8 0.026 0.159
Trh Mm.1363 2.8 0.081 0.264 1.4 0.335 0.160 3.9 0.055 0.293 2.7 0.157 0.239
Lhb Mm.57061 1.7 0.005 0.468 1 0.437 0.367 1.7 0.107 0.598 1.5 0.183 0.478
Gnrh1 Mm.358309 1.6 0.113 0.027 1 0.46 0.159 1.5 0.134 0.313 1.4 0.236 0.166
Fshb Mm.249525 1.1 0.45 0.489 1 0.482 0.160 1.1 0.427 0.126 1.1 0.453 0.258
Ghrh Mn.144157 1.1 0.01 0.291 1 0.133 0.345 1.1 0.281 0.160 1.1 0.106 0.266
Tshb Mm.110730 1.1 0.4 0.334 1 0.497 0.668 1 0.48 0.492 1 0.459 0.498
Actb Mm.391967 1.2 0.406 0.240 1.1 0.844 0.149 1 0.808 0.241 1.1 0.686 0.210
Notes: Statistically signiﬁ  cant expression alterations are highlighted in bold. DPI is the day post-infection. Fold change is average fold change of scrapie vs. mock-infected.   Ave. 
is the average expression of scrapie samples/mock samples. SD is the standard deviation.
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Appendix 3 Spleen gene expression in mice infected with ME7, 22L, and RML-Chandler strains of scrapie vs. mock-infected mice using 
qRT-PCR
D.P.I. Gene symbol Unigene qRT -PCR fold change,  p-value,  and standard deviation
ME7 p-value SD RML p-value SD 22L p-value SD AVE. p-value SD
46 Anp32a Mm.269088 2.1 0.015 0.263 2.4 0.001 0.327 2.0 0.018 0.279 2.2 0.011 0.290
Grn Mm.1568 2.2 0.045 0.056 2.3 0.004 0.133 2.1 0.043 0.252 2.2 0.030 0.147
Ctsz Mm.156919 2.4 0.050 0.280 2.3 0.085 0.357 2.7 0.138 0.257 2.5 0.091 0.298
Hspa4 Mm.239865 2.5 0.066 0.433 2.4 0.202 0.268 1.8 0.059 0.216 2.3 0.109 0.306
Cd68 Mm.15819 1.6 0.103 0.242 1.7 0.135 0.283 1.5 0.237 0.282 1.6 0.158 0.269
Ctss Mm.3619  2.1 0.157 0.107 2.2 0.242 0.148 1.9 0.127 0.170 2.1 0.175 0.142
Iﬁ  tm3 Mm.141021 1.6 0.172 0.435 1.9 0.182 0.365 1.5 0.187 0.357 1.6 0.180 0.329
Iﬁ  t3 Mm.271850 3.0 0.021 0.341 2.9 0.288 0.139 2.3 0.278 0.176 2.7 0.196 0.219
Hspa12a Mm.39739 1.6 0.273 0.271 1.6 0.267 0.230 1.4 0.490 0.223 1.5 0.343 0.242
Iﬁ  t1 Mm.6718 2.4 0.172 0.112 2.1 0.344 0.117 1.2 0.595 0.427 1.9 0.370 0.219
Hspa8 Mm.290774 2.2 0.171 0.143 1.7 0.529 0.115 1.9 0.447 0.116 1.9 0.382 0.125
(Continued)
RML
22L
ME7
Mock
104 dpi 146 dpi
no symptoms symptoms
Appendix 2 GFAP immunoreactivity in scrapie-infected and mock-infected mice at 104 and 146 dpi. Hippocampus region of the brain from sections from ME7, 22L, and 
RML-Chandler-infected mice stained with GFAP antibodies (brown) and counterstained with hematoxylin (blue). Note the increase in GFAP immunoreactivity in the scrapie 
compared to mock-infected mice.
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Appendix 3 (Continued)
D.P.I. Gene symbol Unigene qRT -PCR fold change,  p-value,  and standard deviation
ME7 p-value SD RML p-value SD 22L p-value SD AVE. p-value SD
Olfml3 Mm.211535 1.9 0.183 0.193 1.7 0.438 0.120 1.4 0.567 0.193 1.6 0.396 0.169
HexB Mm.27816 1.6 0.184 0.233 1.6 0.557 0.177 1.7 0.473 0.170 1.6 0.405 0.193
Iﬁ  27 Mm.271275 1.6 0.317 0.209 1.8 0.267 0.270 1.5 0.673 0.320 1.6 0.419 0.266
Gh Mm.343934 1.5 0.428 0.095 1.9 0.340 0.158 1.6 0.492 0.161 1.7 0.420 0.138
H2-T23 Mm.35016 1.6 0.330 0.279 1.5 0.254 0.208 1.6 0.493 0.412 1.5 0.359 0.300
Stat1 Mm.277406 1.5 0.569 0.107 1.8 0.459 0.154 1.4 0.567 0.087 1.6 0.532 0.116
Usp18 Mm.326911 1.5 0.341 0.250 1.4 0.515 0.178 1.3 0.567 0.244 1.4 0.474 0.224
Rtp4 Mm.390891 1.2 0.493 0.130 1.5 0.410 0.382 1.3 0.551 0.341 1.3 0.485 0.284
Gfap Mm.1239 1.4 0.474 0.251 1.3 0.352 0.268 1.3 0.543 0.154 1.3 0.456 0.224
Trem2 Mm.261623 1.9 0.155 0.256 2.0 0.156 0.358 1.4 0.412 0.389 1.8 0.241 0.335
Atp1b1 Mm.4550 0.9 0.472 0.374 0.7 0.186 0.159 0.7 0.254 0.431 0.8 0.304 0.321
Actb Mm.391967 1.2 0.658 0.096 1.2 0.714 0.133 1.1 0.776 0.093 1.2 0.716 0.108
104 Anp32a Mm.269088 1.8 0.031 0.271 1.6 0.044 0.283 1.6 0.037 0.178 1.7 0.037 0.244
Grn Mm.1568 2.6 0.000 0.203 2.0 0.024 0.241 3.0 0.004 0.248 2.5 0.009 0.230
Ctsz Mm.156919 1.9 0.037 0.143 1.4 0.037 0.084 1.6 0.007 0.121 1.6 0.027 0.116
Hspa4 Mm.239865 1.5 0.029 0.146 1.5 0.042 0.151 1.9 0.001 0.281 1.6 0.024 0.192
Cd68 Mm.15819 1.9 0.038 0.151 1.9 0.011 0.296 2.0 0.016 0.119 1.9 0.021 0.188
Ctss Mm.3619  1.5 0.023 0.139 1.7 0.046 0.103 1.6 0.049 0.186 1.6 0.039 0.142
Iﬁ  tm3 Mm.141021 1.7 0.044 0.016 2.0 0.000 0.027 2.2 0.000 0.168 2.0 0.015 0.070
Iﬁ  t3 Mm.271850 1.8 0.005 0.372 2.0 0.002 0.264 2.4 0.004 0.174 2.1 0.004 0.270
Hspa12a Mm.39739 2.1 0.043 0.295 1.9 0.041 0.179 2.0 0.041 0.155 2.0 0.042 0.210
Iﬁ  t1 Mm.6718 2.1 0.044 0.223 2.2 0.044 0.253 2.1 0.046 0.260 2.1 0.045 0.245
Hspa8 Mm.290774 2.4 0.026 0.250 2.2 0.041 0.153 3.0 0.016 0.184 2.6 0.028 0.196
Olfml3 Mm.211535 2.1 0.003 0.161 2.3 0.029 0.193 3.2 0.001 0.178 2.5 0.011 0.177
HexB Mm.27816 1.4 0.025 0.181 1.5 0.012 0.226 1.8 0.012 0.141 1.6 0.016 0.183
Iﬁ  27 Mm.271275 1.7 0.038 0.253 1.4 0.047 0.195 2.1 0.001 0.219 1.7 0.029 0.222
Gh Mm.343934 1.1 0.518 0.394 1.7 0.059 0.362 1.1 0.040 0.454 1.3 0.206 0.403
H2-T23 Mm.35016 1.2 0.280 0.139 1.1 0.424 0.157 1.4 0.204 0.106 1.2 0.303 0.134
Stat1 Mm.277406 1.0 0.448 0.101 1.5 0.207 0.123 2.0 0.185 0.431 1.5 0.280 0.218
Usp18 Mm.326911 2.0 0.165 0.376 1.6 0.265 0.441 2.2 0.046 0.461 1.9 0.159 0.426
Rtp4 Mm.390891 1.0 0.496 0.033 1.0 0.477 0.011 1.1 0.355 0.129 1.0 0.442 0.057
Gfap Mm.1239 1.1 0.437 0.121 1.9 0.178 0.199 1.6 0.226 0.115 1.5 0.280 0.145
Trem2 Mm.261623 1.5 0.227 0.191 1.2 0.358 0.262 1.6 0.292 0.325 1.4 0.293 0.259
Atp1b1 Mm.4550 0.9 0.365 0.156 0.7 0.148 0.222 1.1 0.367 0.133 0.9 0.293 0.170
Actb Mm.391967 1.1 0.727 0.097 1.0 0.938 0.070 1.1 0.836 0.227 1.1 0.833 0.131
146 Anp32a Mm.269088 2.2 0.037 0.093 2.3 0.029 0.188 2.7 0.022 0.110 2.4 0.030 0.130
Grn Mm.1568 1.3 0.044 0.275 1.8 0.024 0.196 2.0 0.014 0.106 1.7 0.027 0.236
Ctsz Mm.156919 1.6 0.041 0.214 2.0 0.011 0.152 2.1 0.021 0.234 1.9 0.024 0.200
Hspa4 Mm.239865 1.8 0.022 0.147 1.7 0.034 0.152 1.9 0.007 0.179 1.8 0.021 0.159
Cd68 Mm.15819 2.0 0.014 0.172 1.9 0.038 0.105 2.1 0.018 0.101 2.0 0.023 0.126
Ctss Mm.3619  1.5 0.032 0.359 1.7 0.012 0.278 1.7 0.027 0.143 1.7 0.024 0.260
Iﬁ  tm3 Mm.141021 1.9 0.007 0.223 2.2 0.002 0.252 1.9 0.022 0.137 2.0 0.010 0.204
Iﬁ  t3 Mm.271850 1.6 0.037 0.234 1.6 0.032 0.175 2.0 0.048 0.284 1.8 0.039 0.231
Hspa12a Mm.39739 2.0 0.010 0.047 2.0 0.022 0.063 2.1 0.017 0.066 2.0 0.016 0.059
Iﬁ  t1 Mm.6718 2.0 0.038 0.140 1.8 0.016 0.065 1.8 0.002 0.065 1.9 0.019 0.082
Hspa8 Mm.290774 1.6 0.038 0.050 1.6 0.034 0.149 1.8 0.017 0.153 1.7 0.029 0.117
(Continued)
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Appendix 3 (Continued)
D.P.I. Gene symbol Unigene qRT -PCR fold change,  p-value,  and standard deviation
ME7 p-value SD RML p-value SD 22L p-value SD AVE. p-value SD
Olfml3 Mm.211535 2.3 0.046 0.260 2.5 0.028 0.145 2.2 0.043 0.000 2.3 0.039 0.135
HexB Mm.27816 1.7 0.020 0.183 1.8 0.014 0.244 1.9 0.019 0.190 1.8 0.018 0.206
Iﬁ  27 Mm.271275 1.5 0.032 0.056 1.7 0.014 0.247 1.8 0.042 0.145 1.7 0.029 0.149
Gh Mm.343934 1.9 0.016 0.036 2.2 0.004 0.344 1.9 0.162 0.170 2.0 0.061 0.184
H2-T23 Mm.35016 1.7 0.041 0.299 1.5 0.028 0.389 2.3 0.039 0.184 1.8 0.036 0.291
Stat1 Mm.277406 1.5 0.265 0.192 1.2 0.334 0.379 1.5 0.188 0.114 1.4 0.262 0.228
Usp18 Mm.326911 1.3 0.101 0.247 1.4 0.110 0.102 1.6 0.168 0.239 1.4 0.126 0.196
Rtp4 Mm.390891 1.1 0.422 0.194 1.1 0.404 0.089 1.5 0.217 0.259 1.2 0.348 0.181
Gfap Mm.1239 1.4 0.512 0.193 1.0 0.994 0.123 1.0 0.986 0.200 1.1 0.832 0.172
Trem2 Mm.261623 1.2 0.246 0.312 1.1 0.350 0.217 1.0 0.491 0.252 1.1 0.362 0.260
Atp1b1 Mm.4550 0.8 0.242 0.096 0.7 0.059 0.196 0.8 0.331 0.156 0.8 0.211 0.149
Actb Mm.391967 1.1 0.785 0.149 1.2 0.557 0.147 1.2 0.764 0.196 1.1 0.702 0.164
Note: Statistically signiﬁ  cant expression alterations are highlighted in bold.
Abbreviations: D.P.I., day post-infection;   Ave, average expression of scrapie samples relative to mock samples;  SD, standard deviation.
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